{"id":1867,"date":"2019-05-10T11:12:56","date_gmt":"2019-05-10T09:12:56","guid":{"rendered":"https:\/\/www.arbios.org\/?p=1867"},"modified":"2019-05-17T12:03:13","modified_gmt":"2019-05-17T10:03:13","slug":"aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status","status":"publish","type":"post","link":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/","title":{"rendered":"Aptys Pharmaservices started its operations in the frame of its GMP status"},"content":{"rendered":"

Founded in 2018, APTYS Pharmaservices is a subsidiary of Aptys Pharmaceuticals.<\/p>\n

APTYS Pharmaservices is a GMP CRO specializing in formulation design, analytical development and validation, quality control and ICH stability.<\/p>\n

Following the complete transfer of the GMP activity and the approval of the French agency ANSM, APTYS Pharmaservices launched its pharmaceutical activities, carrying out quality control operations in partnership with the CMO Europhartech (www.europhartech.com).<\/p>\n

In April, the WHO also confirmed, following its inspection, the qualification of Aptys Pharmaservices for quality control activities.<\/p>\n

 <\/p>\n

APTYS PHARMASERVICES<\/strong><\/span>
\nBiop\u00f4le Clermont-Limagne<\/strong><\/span>
\nPhone: +33 473 670 670
\nContact: Fran\u00e7ois Boutignon |\u00a0contact@aptys-pharmaceuticals.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Founded in 2018, APTYS Pharmaservices is a subsidiary of Aptys Pharmaceuticals. APTYS Pharmaservices is a GMP CRO specializing in formulation design, analytical development and validation, quality control and ICH stability. Following the complete transfer of the GMP activity and the approval of the French agency ANSM, APTYS Pharmaservices launched its pharmaceutical activities, carrying out quality […]<\/p>\n","protected":false},"author":2,"featured_media":1865,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-1867","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nAptys Pharmaservices started its operations in the frame of its GMP status - Arbios<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptys Pharmaservices started its operations in the frame of its GMP status - Arbios\" \/>\n<meta property=\"og:description\" content=\"Founded in 2018, APTYS Pharmaservices is a subsidiary of Aptys Pharmaceuticals. APTYS Pharmaservices is a GMP CRO specializing in formulation design, analytical development and validation, quality control and ICH stability. Following the complete transfer of the GMP activity and the approval of the French agency ANSM, APTYS Pharmaservices launched its pharmaceutical activities, carrying out quality […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\" \/>\n<meta property=\"og:site_name\" content=\"Arbios\" \/>\n<meta property=\"article:published_time\" content=\"2019-05-10T09:12:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-05-17T10:03:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"791\" \/>\n\t<meta property=\"og:image:height\" content=\"298\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"arbios\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"arbios\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\"},\"author\":{\"name\":\"arbios\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"headline\":\"Aptys Pharmaservices started its operations in the frame of its GMP status\",\"datePublished\":\"2019-05-10T09:12:56+00:00\",\"dateModified\":\"2019-05-17T10:03:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\"},\"wordCount\":109,\"image\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\",\"url\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\",\"name\":\"Aptys Pharmaservices started its operations in the frame of its GMP status - Arbios\",\"isPartOf\":{\"@id\":\"https:\/\/www.arbios.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg\",\"datePublished\":\"2019-05-10T09:12:56+00:00\",\"dateModified\":\"2019-05-17T10:03:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage\",\"url\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg\",\"contentUrl\":\"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg\",\"width\":791,\"height\":298},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.arbios.org\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptys Pharmaservices started its operations in the frame of its GMP status\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.arbios.org\/#website\",\"url\":\"https:\/\/www.arbios.org\/\",\"name\":\"Arbios\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.arbios.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b\",\"name\":\"arbios\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.arbios.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g\",\"caption\":\"arbios\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptys Pharmaservices started its operations in the frame of its GMP status - Arbios","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/","og_locale":"en_US","og_type":"article","og_title":"Aptys Pharmaservices started its operations in the frame of its GMP status - Arbios","og_description":"Founded in 2018, APTYS Pharmaservices is a subsidiary of Aptys Pharmaceuticals. APTYS Pharmaservices is a GMP CRO specializing in formulation design, analytical development and validation, quality control and ICH stability. Following the complete transfer of the GMP activity and the approval of the French agency ANSM, APTYS Pharmaservices launched its pharmaceutical activities, carrying out quality […]","og_url":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/","og_site_name":"Arbios","article_published_time":"2019-05-10T09:12:56+00:00","article_modified_time":"2019-05-17T10:03:13+00:00","og_image":[{"width":791,"height":298,"url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg","type":"image\/jpeg"}],"author":"arbios","twitter_card":"summary_large_image","twitter_misc":{"Written by":"arbios"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#article","isPartOf":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/"},"author":{"name":"arbios","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"headline":"Aptys Pharmaservices started its operations in the frame of its GMP status","datePublished":"2019-05-10T09:12:56+00:00","dateModified":"2019-05-17T10:03:13+00:00","mainEntityOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/"},"wordCount":109,"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/","url":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/","name":"Aptys Pharmaservices started its operations in the frame of its GMP status - Arbios","isPartOf":{"@id":"https:\/\/www.arbios.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage"},"image":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage"},"thumbnailUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg","datePublished":"2019-05-10T09:12:56+00:00","dateModified":"2019-05-17T10:03:13+00:00","author":{"@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b"},"breadcrumb":{"@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#primaryimage","url":"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg","contentUrl":"https:\/\/www.arbios.org\/wp-content\/uploads\/2019\/05\/aptys-ansm.jpg","width":791,"height":298},{"@type":"BreadcrumbList","@id":"https:\/\/www.arbios.org\/en\/aptys-pharmaservices-started-its-operations-in-the-frame-of-its-gmp-status\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.arbios.org\/en\/"},{"@type":"ListItem","position":2,"name":"Aptys Pharmaservices started its operations in the frame of its GMP status"}]},{"@type":"WebSite","@id":"https:\/\/www.arbios.org\/#website","url":"https:\/\/www.arbios.org\/","name":"Arbios","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.arbios.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/d4764a06f595d90cc731f0cbaa14ba7b","name":"arbios","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.arbios.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/edc889faeb33c603c9491f1e7966135090d534f607758d58358d3f371a6c8583?s=96&d=mm&r=g","caption":"arbios"}}]}},"_links":{"self":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1867","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/comments?post=1867"}],"version-history":[{"count":3,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1867\/revisions"}],"predecessor-version":[{"id":1887,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/posts\/1867\/revisions\/1887"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media\/1865"}],"wp:attachment":[{"href":"https:\/\/www.arbios.org\/en\/wp-json\/wp\/v2\/media?parent=1867"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}